Your Trusted Medtech Partner

• The European market for enterprise solutions is characterized by growing enthusiasm for enterprise solutions that is hampered by irregular legislative support.
• Compared to the US, the lower adoption of EHRs across the region due to a lack of national incentive programs serves as the most substantial limiter of the overall market.
• Compared to the enterprise solution market in the US, the VNA and enterprise viewer segment in Europe currently accounts for a larger proportion of overall market revenues due to the historically higher acceptance of cross-organizational file-sharing protocols within the region.

• Overall, the European infusion pump market will expand modestly over the forecast period.
• Economic uncertainty across Europe has caused many patients to prioritize their purchases and minimize spending which will slower overall market growth in the early years of the forecast period.
• The insulin pump segment will be driven by moderate growth in the diabetic population in Europe over the forecast period, which will increase at a CAGRof approximately 3 % for both type 1 and type 2 diabetes in all the countries covered.

Learn more

• The US market for skin replacements and substitutes was valued at over $700 million in 2017.
• Changes in reimbursement for skin substitutes in 2014 gave manufacturers incentives to price their products high during the last few years in order to qualify as a high-cost product and maximize profits.
• Although injectable skin substitutes are currently not reimbursed by the CMS, demand for injectable products in cases where applying graft tissues is inhibited by the structure of the wound, such as tunneling wounds, will drive growth in this segment.

• Over the forecast period, the US spinal implant market will experience modest growth driven by the expanding aging population and the uptake of premium technologies.
• In particular, the nonfusion technologies market will be supported by the emergence of long-term clinical data in a number of segments, including interspinous process decompression devices and cervical artificial discs.
• However, the traditional implant market—which make up the majority of the overall spinal implant market—features heavily commoditized products and a large number of competing companies.

• The global dental implant market is extremely lucrative and will continue to be supported by the aging population, rising patient awareness of dental implant procedures, and the increasing adoption of dental implant treatments among dentists.
• The North American market will continue to be important for manufacturers due to its very large size and rapid growth.
• In all regions covered, ASPs will face downward pressures due to the growing presence and uptake of value products, thereby hindering market growth over the forecast period to some extent.